Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
14.3M
-
Shares change
-
+7.01M
-
Total reported value, excl. options
-
$5.44M
-
Value change
-
+$2.03M
-
Put/Call ratio
-
0.01
-
Number of buys
-
19
-
Number of sells
-
-21
-
Price
-
$0.38
Significant Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q2 2025
64 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share as of Q2 2025.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.3M shares
of 101M outstanding shares and own 14.08% of the company stock.
Largest 10 shareholders include DIADEMA PARTNERS LP (2.74M shares), ARMISTICE CAPITAL, LLC (2.69M shares), HEIGHTS CAPITAL MANAGEMENT, INC (1.83M shares), VANGUARD GROUP INC (1.8M shares), MILLENNIUM MANAGEMENT LLC (1.49M shares), 683 Capital Management, LLC (1M shares), Persistent Asset Partners Ltd (641K shares), GEODE CAPITAL MANAGEMENT, LLC (448K shares), SIMPLEX TRADING, LLC (228K shares), and SABBY MANAGEMENT, LLC (170K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.